Management of Asthma Exacerbation in a 6-Year-Old Despite Two Inhalers
For a 6-year-old child experiencing an asthma exacerbation despite using both a reliever (albuterol) and controller (fluticasone) inhaler, add ipratropium bromide to albuterol for immediate relief, initiate a short course of oral corticosteroids (1-2 mg/kg/day of prednisone for 3-10 days), and assess for potential triggers and adherence issues. 1
Immediate Management of the Exacerbation
Step 1: Assess Severity
- Evaluate ability to speak in complete sentences
- Check respiratory rate (mild exacerbation: <25 breaths/min)
- Monitor heart rate (mild exacerbation: <110 beats/min)
- Assess work of breathing and oxygen saturation 2
Step 2: Intensify Rescue Medication
- Administer albuterol via MDI with spacer: 4-8 puffs every 20 minutes for 3 doses, then every 1-4 hours as needed 1, 2
- For nebulizer treatment: 0.075 mg/kg (minimum dose 1.25 mg) every 20 minutes for 3 doses 1
- Add ipratropium bromide:
Step 3: Add Systemic Corticosteroids
- Initiate oral prednisone/prednisolone: 1-2 mg/kg/day (maximum 60 mg/day) for 3-10 days 1
- No need to taper for courses less than 1 week 1
Post-Exacerbation Assessment
Evaluate Medication Adherence
- Check inhaler technique with both devices
- Verify dosing frequency and timing
- Assess understanding of maintenance vs. rescue medication use 1, 3
Identify Potential Triggers
- Environmental allergens (dust mites, pet dander)
- Recent respiratory infections
- Exercise-induced symptoms
- Weather changes
- Indoor air quality issues 1
Review Current Controller Therapy
- Assess if current controller dose is adequate
- For mild persistent asthma: low-dose inhaled corticosteroid (ICS) is the preferred controller 1, 2
- For moderate persistent asthma: consider step-up options 1
Step-Up Options for Inadequately Controlled Asthma
Option 1: Increase ICS Dose
- If currently on low-dose fluticasone, consider increasing to medium-dose range 1
- Note: Evidence shows that increasing ICS dose alone may not be sufficient for exacerbation prevention 4
Option 2: Add Second Controller Medication
- For children ≥4 years: Consider adding long-acting beta-agonist (LABA) to ICS 1, 5
- For children <4 years: Consider adding leukotriene receptor antagonist (LTRA) like montelukast 1
- Note: Combination ICS-LABA therapy provides better control than increasing ICS dose alone in children ≥4 years 1, 5
Important Considerations and Pitfalls
Common Pitfalls to Avoid
- Failing to assess inhaler technique - proper spacer use is critical for effective medication delivery in children 2
- Not addressing adherence issues before stepping up therapy 3
- Overlooking alternative diagnoses or comorbidities that may mimic or worsen asthma 3, 6
- Neglecting to provide a written asthma action plan for future exacerbations 1
Monitoring for Side Effects
- Monitor for tachycardia and tremors with increased albuterol use 2, 7
- Be aware of potential hypokalemia with repeated beta-agonist dosing 7
- For systemic corticosteroids: monitor for short-term effects like increased appetite, mood changes, and sleep disturbances 1
- For long-term ICS: monitor growth velocity 1, 2
When to Refer to a Specialist
- If symptoms persist despite adherence to step 3 or 4 therapy
- If the child has had life-threatening asthma exacerbations
- If there are significant comorbidities complicating management
- If the diagnosis is uncertain 3, 6
Remember that proper technique with spacer devices is essential for effective medication delivery in children. Always ensure the child is using age-appropriate devices and that both the child and caregivers understand proper administration techniques.